Ming-Feng Lin
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
- Vibrio bacteria research studies
- Escherichia coli research studies
Papers in
-
- Antibiotic Resistance in Bacteria 23
-
- Vibrio bacteria research studies 8
- Co-authors
- Chung‐Yu Lan (12 shared papers)Yun-You Lin (10 shared papers)Ming‐Li Liou (13 shared papers)Hui‐Wen Yeh (3 shared papers)Chih‐Man Yang (7 shared papers)Kai‐Chih Chang (6 shared papers)Han‐Yueh Kuo (5 shared papers)Chung‐Hui Lin (3 shared papers)
In The Last Decade
Ming-Feng Lin
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 887
- Endocrinology 361
- Applied Microbiology and Biotechnology 111
- Pollution 200
- Microbiology 71
Countries citing papers authored by Ming-Feng Lin
This map shows the geographic impact of Ming-Feng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Feng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Feng Lin more than expected).
Fields of papers citing papers by Ming-Feng Lin
This network shows the impact of papers produced by Ming-Feng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Feng Lin. The network helps show where Ming-Feng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming-Feng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 284 | |
| 2 | 2014 | 104 | |
| 3 | 2017 | 83 | |
| 4 | 2015 | 78 | |
| 5 | 2003 | 66 | |
| 6 | 2015 | 60 | |
| 7 | 2009 | 53 | |
| 8 | 2011 | 46 | |
| 9 | Pyogenic psoas abscess: analysis of 27 cases. | 1999 | 44 |
| 10 | 2009 | 32 | |
| 11 | 2015 | 31 | |
| 12 | Characterization of antimicrobial resistance patterns and integrons in human fecal Escherichia coli in Taiwan. | 2009 | 26 |
| 13 | Role of integrons in antimicrobial susceptibility patterns of Acinetobacter baumannii. | 2010 | 24 |
| 14 | 2020 | 23 | |
| 15 | 2013 | 23 | |
| 16 | Molecular epidemiology and antimicrobial resistance determinants of multidrug-resistant Acinetobacter baumannii in five proximal hospitals in Taiwan. | 2011 | 22 |
| 17 | 2009 | 20 | |
| 18 | 2011 | 20 | |
| 19 | 2010 | 20 | |
| 20 | 2009 | 16 |
About Ming-Feng Lin
Ming-Feng Lin is a scholar working on Molecular Medicine, Endocrinology, Molecular Biology, Epidemiology and Pharmacology, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (23 papers), Vibrio bacteria research studies (8 papers), Bacterial biofilms and quorum sensing (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Urinary Tract Infections Management (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Streptococcal Infections and Treatments (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Molecular Medicine (887 citations), Endocrinology (361 citations), Applied Microbiology and Biotechnology (111 citations), Pollution (200 citations) and Microbiology (71 citations). Ming-Feng Lin has collaborated with scholars based in Taiwan, Italy and China. Frequent co-authors include Chung‐Yu Lan, Yun-You Lin, Ming‐Li Liou, Hui‐Wen Yeh, Chih‐Man Yang, Kai‐Chih Chang, Han‐Yueh Kuo, Chung‐Hui Lin, Yu‐Hung Lin and Bea‐Ven Chang. Their work appears in journals such as Journal of Microbiology Immunology and Infection, Journal of Hospital Infection, PLoS ONE, Microbial Drug Resistance and PeerJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.